High UBE2D1 expression is associated with poor prognosis and immunotherapy resistance in head and neck cancer
UBE2D1 is frequently overexpressed in HNSCC and is associated with adverse clinical outcomes. Although its association with immunotherapy response requires further validation, UBE2D1 may be a prognostic biomarker in HNSCC.
Authors
- Prathibha Prasad
- Paramasivam Arumugam
Institutions
- Ajman University (AE)
- Saveetha University (IN)
Publication Details
- Journal
- Journal of Oral Biology and Craniofacial Research
- Published
- 2026-02-14
- DOI
- https://doi.org/10.1016/j.jobcr.2026.101423
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00